Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: a systematic review and individual patient data meta-analysis.
Journal: The lancet. Psychiatry
Published: October 22, 2024
Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment.
Journal: Cephalalgia : an international journal of headache
Published: February 14, 2020
Trial of Galcanezumab in Prevention of Episodic Cluster Headache.
Journal: The New England journal of medicine
Published: July 11, 2019
Effects of the cannabinoid-1 receptor antagonist/inverse agonist rimonabant on satiety signaling in overweight people with schizophrenia: a randomized, double-blind, pilot study.
Journal: Journal of clinical psychopharmacology
Published: January 02, 2013
Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis.
Journal: Neuropsychiatric disease and treatment
Published: June 30, 2012
Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States.
Journal: Journal of medical economics
Published: February 07, 2012
Dopamine pathology in schizophrenia: analysis of total and phosphorylated tyrosine hydroxylase in the substantia nigra.
Journal: Frontiers in psychiatry
Published: December 27, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026